AI assistant
CONMED Corp — Director's Dealing 2012
Jun 5, 2012
31971_dirs_2012-06-05_639e1ef8-76cd-4971-aa9b-fdfdc9476c4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-06-01
Reporting Person: POMILIO LUKE A (Vice President & Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-01 | Common Stock | M | 800 | — | Acquired | 13843 | Direct |
| 2012-06-01 | Common Stock | F | 290 | $26.09 | Disposed | 13553 | Direct |
| 2012-06-01 | Common Stock | M | 800 | — | Acquired | 14353 | Direct |
| 2012-06-01 | Common Stock | F | 290 | $26.09 | Disposed | 14063 | Direct |
| 2012-06-01 | Common Stock | M | 800 | — | Acquired | 14863 | Direct |
| 2012-06-01 | Common Stock | F | 290 | $26.09 | Disposed | 14573 | Direct |
| 2012-06-01 | Common Stock | M | 800 | — | Acquired | 15373 | Direct |
| 2012-06-01 | Common Stock | F | 290 | $26.09 | Disposed | 15083 | Direct |
| 2012-06-01 | Common Stock | M | 1000 | — | Acquired | 16083 | Direct |
| 2012-06-01 | Common Stock | F | 363 | $26.09 | Disposed | 15720 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2018-06-01 | Common Stock (800) | Direct |
| 2012-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2019-06-01 | Common Stock (800) | Direct |
| 2012-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2020-06-01 | Common Stock (800) | Direct |
| 2012-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2021-06-01 | Common Stock (800) | Direct |
| 2012-06-01 | Rsus (restricted Stock Units) | $0 | M | 1000 | Disposed | 2021-07-29 | Common Stock (1000) | Direct |
| 2012-06-01 | Rsus (restricted Stock Units) | $0 | A | 4000 | Acquired | 2022-06-01 | Common Stock (4000) | Direct |
| 2012-06-01 | Sars (Stock Appreciation Rights) | $26.09 | A | 10000 | Acquired | 2022-06-01 | Common Stock (10000) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a five year period with the first 20% of the RSU's vesting June 1, 2012.
F4: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.